PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2016.34.1.76201634176-80Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literatureDeepa Joseph, Monica Malik Irukulla, Syed Fayaz Ahmed, Deepthi Valiyaveettil, Syed Akramhttp://www.e-roj.org/upload/pdf/roj-34-76.pdf, http://www.e-roj.org/journal/view.php?doi=10.3857/roj.2016.34.1.76, http://www.e-roj.org/upload/pdf/roj-34-76.pdf
SKIN The Journal of Cutaneous Medicine10.25251/skin.2.6.122018Microsporum Canis Infection Presenting As Cutaneous Pseudolymphoma. Case Report And Review Of The LiteratureLizy Paniagua, Adrian Subrt, Bernard Gibsonhttp://ojs3x.jofskin.org/index.php/skin/article/download/222/pdf_1, http://ojs3x.jofskin.org/index.php/skin/article/download/222/pdf_1
Reactions Weekly10.1007/s40278-019-70710-x201917771127-127Ibrutinibhttp://link.springer.com/content/pdf/10.1007/s40278-019-70710-x.pdf, http://link.springer.com/article/10.1007/s40278-019-70710-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-70710-x.pdf
Reactions Weekly10.1007/s40278-015-5617-020151570145-45Ciclosporinhttp://link.springer.com/content/pdf/10.1007/s40278-015-5617-0.pdf, http://link.springer.com/article/10.1007/s40278-015-5617-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-5617-0
Reactions Weekly10.1007/s40278-018-54759-7201817291129-129Gabapentinhttp://link.springer.com/content/pdf/10.1007/s40278-018-54759-7.pdf, http://link.springer.com/article/10.1007/s40278-018-54759-7/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-54759-7.pdf
Pathology10.1016/j.pathol.2018.12.200201951S80A double dose of pseudolymphoma: Cutaneous intravascular CD30+ pseudolymphoma arising in acral pseudolymphomatous angiokeratoma – a case reportIngrid Fewings, Genevieve Bennett, Adrienne Moreyhttps://api.elsevier.com/content/article/PII:S0031302518308651?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0031302518308651?httpAccept=text/plain
Reactions Weekly10.1007/s40278-014-9662-x2014149415-5Adalimumab/infliximabhttp://link.springer.com/content/pdf/10.1007/s40278-014-9662-x.pdf, http://link.springer.com/article/10.1007/s40278-014-9662-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-9662-x
Reactions Weekly10.1007/s40278-015-10063-y201515751122-122Infliximab/rituximabhttp://link.springer.com/content/pdf/10.1007/s40278-015-10063-y.pdf, http://link.springer.com/article/10.1007/s40278-015-10063-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-10063-y
Reactions Weekly10.1007/bf0329408320121387133-33Zoledronic acidhttp://link.springer.com/content/pdf/10.1007/BF03294083.pdf, http://link.springer.com/article/10.1007/BF03294083/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03294083
Reactions Weekly10.1007/s40278-016-21246-x20161619163-63Ciclosporinhttp://link.springer.com/content/pdf/10.1007/s40278-016-21246-x.pdf, http://link.springer.com/article/10.1007/s40278-016-21246-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-21246-x.pdf